Maple Securities USA’s Labcorp LH Stock Holding History

Maple Securities USA’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-7,040	Closed	-$553K	–	277
2013 Q4	$553K	Buy	+7,040	New	+$600K	0.04%	180

Other funds holding LH

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

PIM

Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Maple Securities USA's LH Position: Q1 2014 in Review

Maple Securities USA sold out of Labcorp (LH) in Q1 2014, closing a stake of 7,040 shares — an estimated $553K sold.

Maple Securities USA first reported a position in LH in Q4 2013 and held it in 1 quarter. The position peaked at $553K in Q4 2013. 526 funds tracked by Wall St. Rank hold LH as of Q1 2014.

Maple Securities USA reported no remaining Labcorp position as of Q1 2014 after selling out during the quarter.
Maple Securities USA sold 7,040 Labcorp shares in Q1 2014, an estimated $553K.
Maple Securities USA first reported a position in Labcorp in Q4 2013 and held it in 1 quarter.
Maple Securities USA's Labcorp position peaked at $553K in Q4 2013.
526 funds tracked by Wall St. Rank held Labcorp as of Q1 2014.

Based on Maple Securities USA's 13F filing for Q1 2014, filed 24 Apr 2014.